Article
Immunology
Masaru Yoshizumi, Naoya Tazawa, Chizuko Watanabe, Hirokazu Mizoguchi
Summary: Activation of TRPV4 can negatively regulate bladder inflammation induced by LPS and alleviate bladder hypersensitivity. This finding may provide new therapeutic targets for refractory bladder pain syndrome.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Tadeja Kuret, Dominika Peskar, Mateja Erdani Kreft, Andreja Erman, Peter Veranic
Summary: Urothelial cells in IC/BPS show upregulation of proinflammatory mediators after TNF alpha stimulation, suggesting their active role in shaping the local immune response of the bladder. Our study provides insights into the phenotype and function of urothelial cells in an inflammatory environment and confirms the role of TNF alpha signaling in IC/BPS pathology.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Medicine, General & Internal
Pedro-Santiago Borrego-Jimenez, Javier Flores-Fraile, Barbara-Yolanda Padilla-Fernandez, Sebastian Valverde-Martinez, Agustin Gomez-Prieto, Magaly Teresa Marquez-Sanchez, Jose-Antonio Miron-Canelo, Maria-Fernanda Lorenzo-Gomez
Summary: The study demonstrated the benefits of using biofeedback as an adjunct therapy for women with bladder pain syndrome/interstitial cystitis, improving patients' quality of life.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Wan-Ru Yu, Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo
Summary: This study found significantly higher levels of urinary cytokines and chemokines in patients with IC/BPS, which were closely associated with bladder conditions and treatment outcomes.
Article
Pharmacology & Pharmacy
Zhinoos Taidi, Tommy Zhou, Kate H. Moore, Kylie J. Mansfield, Lu Liu
Summary: Inflammatory conditions of the urinary bladder are associated with urothelial damage and loss of function. The purinergic P2X7 receptor plays a role in such inflammatory conditions and may be a new therapeutic target for bladder inflammation.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Chemistry, Medicinal
Yunpeng Shao, Yu Liu, Baixin Shen, Qiao Zhou, Zhongqing Wei
Summary: Interstitial cystitis (IC) is characterized by apoptosis and chronic inflammation in bladder tissue. This study found that echinacoside (ECH) can improve bladder function, reduce inflammatory damage, and decrease apoptosis in IC models. The protective effect of ECH against IC in the bladder may be mediated through modulation of the PPAR gamma/NF-kappa B pathway.
JOURNAL OF MEDICINAL FOOD
(2022)
Article
Pharmacology & Pharmacy
Masaru Yoshizumi, Chizuko Watanabe, Hirokazu Mizoguchi
Summary: This study established a chronic cystitis model in rats using LPS and investigated the effects of gabapentin on bladder hypersensitivity. The results showed that LPS injections induced long-lasting bladder inflammation, pain, and overactivity in the rats, while gabapentin effectively managed these symptoms in the chronic cystitis model.
PHARMACOLOGY RESEARCH & PERSPECTIVES
(2021)
Article
Physiology
Yoshiyuki Akiyama, Jian-Rong Yao, Karl J. Kreder, Michael A. O'Donnell, Susan K. Lutgendorf, Dan Lyu, Daichi Maeda, Haruki Kume, Yukio Homma, Yi Luo
Summary: This study established a novel animal model for Hunner-type interstitial cystitis (HIC) using a transgenic mouse model (URO-OVA) through autoimmunity to the bladder urothelium. The model reproduced histological and clinical features of human HIC, providing a valuable tool for HIC research.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Yuan-Hong Jiang, Jia-Fong Jhang, Yuan-Hsiang Hsu, Hann-Chorng Kuo
Summary: This study investigated the usefulness of urinary biomarkers in assessing bladder condition and histopathology in IC/BPS patients. The results show that urinary biomarker levels are associated with symptoms and pathological manifestations, helpful in identifying HIC and NHIC subtypes, but most biomarkers are not strongly correlated with specific bladder histopathological findings.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Urology & Nephrology
Jayoung Kim, Amanda De Hoedt, Emily Wiggins, Kelsey Haywood, Peng Jin, Bennett Greenwood, Niven R. Narain, Vladimir Tolstikov, Valerie Bussberg, Kamil E. Barbour, Michael A. Kiebish, Stephen J. Freedland, Jennifer T. Anger
Summary: The study aimed to identify potential biomarkers of interstitial cystitis/painful bladder syndrome (IC) by analyzing urine and serum metabolomes of IC patients and non-disease controls. The analysis revealed distinct metabolomic profiles in IC patients, with specific markers identified in urine samples. Integrated analyses of key metabolites showed promising biomarkers for the pathophysiology of IC.
Article
Pharmacology & Pharmacy
Jiang Zhao, Shan Chen, Chengfei Yang, Mi Zhou, Teng Yang, Bishao Sun, Jingzheng Zhu, Hengshuai Zhang, Qudong Lu, Longkun Li, Zhenxing Yang, Bo Song, Wenhao Shen, Shanhong Yi, Shuangshuang Dai
Summary: This study demonstrates the involvement of the abnormal activation of the CXCL13/CXCR5 axis in the pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS). Blocking the activation of the CXCL13/CXCR5 axis by TAK-779 effectively reduces bladder inflammation and improves bladder function.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Chemistry, Multidisciplinary
Maryam Fatima, Irfan Anjum, Aamir Abdullah, Shaun Zshaan Abid, Muhammad Nasir Hayat Malik
Summary: The study demonstrates the protective effect of boswellic acids on cyclophosphamide-induced cystitis in rats, indicating their potential as therapeutic alternatives for cystitis. Boswellic acids exhibit antioxidant and anti-inflammatory properties, reducing urothelial damage and inflammation.
Article
Biochemistry & Molecular Biology
Yuan-Hong Jiang, Jia-Fong Jhang, Lori A. A. Birder, Hann-Chorng Kuo
Summary: The aim of this study was to investigate the expression levels of sensory receptors, inflammatory proteins, and pro-apoptotic proteins in the urothelium of non-Hunner's interstitial cystitis (NHIC) bladders of patients with different clinical and cystoscopic phenotypes. The study concluded that IC/BPS patients with frequency and bladder pain complaints have higher levels of urothelial sensory receptors, and inflammatory and pro-apoptotic proteins. The expression levels of these sensory receptors, inflammatory proteins, and pro-apoptotic proteins are not significantly different among IC/BPS bladders with different conditions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, Research & Experimental
Robert M. Moldwin, Vishaan Nursey, Oksana Yaskiv, Siddhartha Dalvi, Eric J. Macdonald, Michael Funaro, Chengliang Zhang, William DeGouveia, Marina Ruzimovsky, Horacio R. Rilo, Edmund J. Miller, Souhel Najjar, Inna Tabansky, Joel N. H. Stern
Summary: Interstitial cystitis/bladder pain syndrome patients with Hunner lesions (HL) show local inflammatory events and increased levels of immune cells. Urinary levels of different cytokines are also elevated in HL patients, indicating different disease processes compared to patients without HL.
JOURNAL OF TRANSLATIONAL MEDICINE
(2022)
Article
Medicine, General & Internal
Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo
Summary: This study analyzed the differences in urinary cytokines and chemokines between different subtypes of interstitial cystitis/bladder pain syndrome (IC/BPS), particularly ulcer (HIC) and non-ulcer subtypes. The results showed that elevated urine levels of IL-8, CXCL10, BDNF, IL-6, and RANTES may indicate the presence of HIC. These findings suggest that urinary biomarkers may be useful for discriminating HIC patients from controls.